Pomahope 3mg capsules | Pomalidomide |Millionpharma
POMAHOPE 3MG MULTIPLE MYELOMA DESCRIPTION Pomalidomide is sold under the brand name Pomahope 3mg and it belongs to anti-neoplastic drugs Pomahope 3mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomahope 3mg combination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomahope 3mg is used in the treatment of Multiple Myeloma condition. In this condition, Pomahope 3mg capsules is used by combining with dexamethasone. Pomahope 3mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomahope 3mg treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomahope has three primary pharmacological activi...